Paragon Intellectual Properties
Founded Year
2004Stage
Other Investors | AliveAbout Paragon Intellectual Properties
Nexeon MedSystems is committed to improving lives through the development of therapies for people with cardiovascular disease. With proven medical device research and development talent, a strong intellectual property portfolio and the leadership of a veteran interventional cardiologist, Nexeon has created an pipeline of products for unmet clinical needs.
Paragon Intellectual Properties Headquarter Location
300 Capitol Street Suite 1002
25301,
United States
Latest Paragon Intellectual Properties News
Nov 29, 2016
Advertisement Topics Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 22:26 EST 28 Nov 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC since January 2007. Key Findings Provides intelligence on Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC and its subsidiaries since 2007. Information about key financial and legal advisors for Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC's financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Nexeon MedSystems, Inc. formerly Paragon Intellectual Properties, LLC's growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
When was Paragon Intellectual Properties founded?
Paragon Intellectual Properties was founded in 2004.
What is Paragon Intellectual Properties's latest funding round?
Paragon Intellectual Properties's latest funding round is Other Investors.
Who are the investors of Paragon Intellectual Properties?
Investors of Paragon Intellectual Properties include SurModics.
Who are Paragon Intellectual Properties's competitors?
Competitors of Paragon Intellectual Properties include Sonivate Medical, Aethlon Medical, HistoSonics, Mercator MedSystems, Intercure and 11 more.
You May Also Like
Cardiogenesis is a medical device company committed to innovating tools for the treatment of cardiovascular disease. The company, located in Orange County, California, is a provider in laser revascularization and angiogenic therapies for the treatment of severe angina.
Vascure is a medical device company. The company is developing an therapeutic device for percutaneous treatment of arterial disease. Vascure's system will offer a one-stop solution for restoring blood flow to narrowed or occluded blood vessels in a range of clinical conditions, including heavily calcified lesions. Vascure will provide Intervantionalists with a safe and easy to use device, shortening procedure time, allowing percutaneous treatment in cases previously requiring radical surgical procedures and generating improved clinical outcomes.
HistoSonics develops a device that uses ultrasound pulses to treat prostate disease. The device is a non-invasive soft tissue ablation modality that mechanically homogenizes target tissue resulting in complete cellular destruction. As a non-thermal modality, histotripsy ablates tissue with no thermal injury. The liquefied tissue is absorbed or voided without remnants or scarring.
ADVOS is a combined multi-organ support system for liver, lung, kidney, and acid-base balance. Based on the principle of albumin dialysis, ADVOS allows both extracorporeal elimination of CO2, hepatic toxins, and water-soluble & protein-bound nephrotoxins, as well as the correction of metabolic and respiratory acidosis. The ADVOS procedure works with dialysis-usual access and flow rates and does not require a gas exchanger for CO2 elimination.
Aethlon Medical is the developer of the Hemopurifier - medical device that aims to treat infectious disease.
Magneceutical Health is in the Complementary and Alternative Medicine market, and is dedicated to helping people improve their health and wellness by enhancing relaxation through the use of natural and holistic magnetic fields.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.